Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aurore Cleret"'
Autor:
Jonathan Blachier, Aurore Cleret, Nathalie Guerin, Clara Gil, Jean-Marc Fanjat, Florian Tavernier, Laura Vidault, Fanny Gallix, Nicolas Rama, Rodrigue Rossignol, Diana Piedrahita, Aurély Andrivon, Marie Châlons-Cottavoz, Karine Aguera, Fabien Gay, Françoise Horand, Bastien Laperrousaz
Publikováno v:
Experimental Cell Research. 426:113568
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d99a5fd3fd7cb9e719e5e894d82e3bba
https://doi.org/10.1016/j.yexcr.2023.113568
https://doi.org/10.1016/j.yexcr.2023.113568
Autor:
Lars Petter Jordheim, M. Lachat, Eva-Laure Matera, L. Molina, L. Conilh, Minh Ngoc Duong, Kamel Chettab, S. Beaumel, Aline Geneste, Charles Dumontet, Aurore Cleret
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-12 (2020)
BMC pharmacology & toxicology, vol. 21, no. 1, pp. 61
BMC Pharmacology & Toxicology
BMC pharmacology & toxicology, vol. 21, no. 1, pp. 61
BMC Pharmacology & Toxicology
Background The existence of a cross-talk between peritumoral adipocytes and cancer cells has been increasingly investigated. Several studies have shown that these adipocytes protect tumor cells from the effect of anticancer agents. Methods To investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba151996dc9efa60110975da8375bbe0
http://link.springer.com/article/10.1186/s40360-020-00436-z
http://link.springer.com/article/10.1186/s40360-020-00436-z
Autor:
Kamel Chettab, Aline Geneste, Aurore Cleret, Philippe Valet, Lars Petter Jordheim, Sabine Beaumel, Minh Ngoc Duong, Emmanuel Delay, Charles Dumontet
Publikováno v:
Cancer Research. 78:5835-5835
Adipose tissue is often reduced to its role in fat storage and metabolic support for tumor cells. However, several studies have shown an adipocyte-mediated resistance effect to various anticancer therapies. However, the responsible agent(s), the mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d55850732acf0aa926a3ce0370f0e806
https://doi.org/10.1158/1538-7445.am2018-5835
https://doi.org/10.1158/1538-7445.am2018-5835
Autor:
Abdelkamel Chettab, Ariel Savina, Juliette Sauveur, Eva Matera, Aurore Cleret, Charles Dumontet
Publikováno v:
Cancer Research. 76:309-309
Background: Overexpression of Human Epidermal growth factor Receptor 2 (HER2) in cancer was associated with poor outcome and high chances of recurrence before the development of anti-HER2 agents. Trastuzumab emtansine (T-DM1) is an antibody-drug conj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff0381a79886011f2612d98aa8361dcb
https://doi.org/10.1158/1538-7445.am2016-309
https://doi.org/10.1158/1538-7445.am2016-309
Autor:
Eva-Laure Matera, Sandrine Valsesia-Wittmann, Charles Dumontet, Béatrice Clémenceau, Minh Ngoc Duong, Aurore Cleret, Kamel Chettab, Doriane Poloni
Publikováno v:
Cancer Research. 74:3783-3783
Background : Trastuzumab is a monoclonal antibody that has been approved in the treatment of HER2-expressing breast cancer. Despite its efficacy, resistance often occurs. Little is known about the role of the tumor microenvironment in resistance to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2145ed5a5b4040fcfaff21e4bce7f251
https://doi.org/10.1158/1538-7445.am2014-3783
https://doi.org/10.1158/1538-7445.am2014-3783